KamataMTadaY. Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review. Int J Mol Sci. 2020;21(5):1690. Published 2020 Mar 1. doi:10.3390/ijms21051690
2.
WolfDSkupMYangH, et al.Clinical outcomes associated with switching or discontinuation from anti-TNF inhibitors for nonmedical reasons. Clin Ther. 2017;39(4):849–862.e6. doi:10.1016/j.clinthera.2017.03.005
3.
TeepleAGinsburgSHowardL, et al.Patient attitudes about non-medical switching to biosimilars: results from an online patient survey in the United States. Curr Med Res Opin. 2019;35(4):603–609. doi:10.1080/03007995.2018.1560221
